>
|
 |
ֺ, Ҿ ũк ȯ ̶ ġ ǥ
|
|
|
|
̶ Ҿ ȯڱ
|
|
|
|
|
|
|
۸ ڣ
Ҿ ũк ȯ ̶ ġῡ 3 ӻ Ȯεƴ.
ֺ 25 3 ӻ IMAgINE-1 м ʷ Ⱓ ȯ ǰ (patient-reported health outcomes) ǥߴ.
̹ ġ Ÿ ʰų ༺ Ǵ ݱ 6~17 Ҿ Ȱ ũк ȯڸ ̶ ̵ ǰ (HRQOL, health-related quality of life) Ҿ ȯ ȣ 뵿꼺 ģ 52° ߴ.
̹ м Ʈ ֱ ũк忰ⱸ(ECCO) 8 мȸ ǥƴ.
״ MC-Ǿ ȳ C. Ŀ α ȯ ġ Ȯϱ Ҿ ũк ȯ ־ ӻ ǰ ô θ ϴ ߿ϴ١鼭 ̹ 3 ӻ 迡 м Ƿ Ӹ ƴ϶ Ⱓ ġ Ҿ ũк ΰ ִ ȯڵ鿡 ū ġ ο ̶͡ ߴ.
IMAgINE-1 Ҿ ũк ȯڵ ǰ (HRQOL) ̶ ϱ IMPACT III ̿ߴ. IMPACT , ü(body image), /ȸ , , ˻/ġ ֿ 6 ǰ (HRQOL) ߴ.
10 ̻ Ҿ ũк ȯ 176 Ϸ ġᰳ 12, 26, 52° ̷. ġ IMPACT III ǰ ° Ÿ.
м ̹ ǥ 뷮 ̶ ġᱺ ġ 12, 26, 52° ġ ǰ ϰ ƴ. IMPACT III 10.8 ʰ ӻ ǹ ִ ƴ.
̱ ڳƼ S. ̾ ڻ Ҿ ũк üγ ȸ ſ ߿ ߴ ñ ü, /ȸ ǰ Ȱ ȯ ٰ ġ ȯ̴. ̹ Ҿ ȯڿ adalimumab ġḦ ߴ. 1 ȿ ܿ ȯ ־. ̴ ȯڵ õ ż ǹѴ١ ߴ.
Ҿ ũк 200,000 Ƶ ΰ ִ ġ ȭ (gastrointestinal, GI) ȯ̴. ũк ȯ ַ κа κп Ѵ. ȯ ȯڵ鿡 ȸ δ , ȯڿ ȯ ȣ ȭ Ų.
ֺ ۷ι R&D κ 鿪 ӻ λ ġ ڻ Ư ǰ ߵ ȯ ʹ ġ ȯ ϻ Ȱ ִ ϴµ ִ. ֺ ̹ ϸ ̶ ̰ ġ ȯ Ҿ ȯڵ ٸ ȯڵ ִ ̶͡ ߴ.
(acepark@mdtoday.co.kr)
<ǰ ̴ ѹα ǥ Ƿ, ǰ Ź , >
|
|
|
|